D. Western Therapeutics Institute, Inc.

DB:6DW Stock Report

Market Cap: €23.1m

D. Western Therapeutics Institute Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 6DW?
Owner TypeNumber of SharesOwnership Percentage
Institutions-230,512-0.607%
Private Companies340,0000.895%
Individual Insiders6,884,80018.1%
General Public30,980,93881.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.2%.


Top Shareholders

Top 13 shareholders own 26.14% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.03%
Hiroyoshi Hidaka
3,428,800€2.1m0%no data
7.69%
Yuichi Hidaka
2,922,100€1.8m0%no data
2.15%
Ueda Yagi Tanshi Co. Ltd., Asset Management Arm
817,700€497.0k0%0.14%
1.97%
SBI Holdings Inc., Asset Management Arm
749,575€455.6k0%0.03%
1.5%
Rakuten Investment Management, Inc.
569,600€346.2k0%0.03%
0.9%
Meat Planning Co., Ltd.
340,000€206.6k0%no data
0.86%
Matsui Securities Co. Ltd., Asset Management Arm
326,900€198.7k0%0.15%
0.69%
Teruo Isohata
260,200€158.1k0%no data
0.66%
Fumishige Ehira
250,000€151.9k0%no data
0.63%
au Kabucom Securities Co., Ltd., Asset Management Arm
238,400€144.9k0%0.13%
0.047%
Yoshiyuki Yamakawa
18,000€10.9k0%no data
0.015%
Sayako Matsubara
5,600€3.4k0%no data
0.00026%
Eisaku Nakamura
100€60.00%no data